Table 1

Clinical characteristics of the patients in group N (no remodelling) and group R (remodelling)

CharacteristicGroup N (n=27)Group R (n=23)p Value
Values are n or mean (SEM).
ACE, angiotensin converting enzyme; CRP, C reactive protein; LVEDP, left ventricular end diastolic pressure; LVEDVI, left ventricular end diastolic volume index; LVEF, left ventricular ejection fraction; LVESVI, left ventricular end systolic volume index; LVMI, left ventricular mass index; MAP, mean aortic pressure; NYHA, New York Heart Association.
Age (years) 65 (2) 66 (2) 0.67
Sex (male/female) 20/7 14/9 0.32
NYHA functional class 0.0063
    I 11 2
    II 9 8
    III 6 10
    IV 1 3
Diagnosis
    Coronary artery disease 17 14 0.88
    Valvar heart disease 7 12 0.057
    Thoracic aortic disease 4 0 0.11
    Other 1 0>0.9999
Comorbidities
    Hypertension 14 15 0.34
    Renal failure 6 6 0.19
    Positive CRP 4 1 0.36
    Diabetes mellitus 10 8>0.9999
    Unstable angina 0 3 0.090
    Acute myocardial infarction 1 2 0.59
    Old myocardial infarction 3 9 0.021
Haemodynamic variables
    Heart rate (beats/min) 72 (3) 78 (3) 0.10
    MAP (mm Hg) 89 (2) 89 (3) 0.85
    LVEDVI (ml/m2) 65 (3)121 (5)<0.0001
    LVESVI (ml/m2) 24 (3) 71 (5)<0.0001
    LVEF (%) 66 (3) 42 (3)<0.0001
    LVMI (g/m2)141 (9)193 (14) 0.0017
    LVEDP (mm Hg) 12 (1) 15 (2) 0.097
Preoperative drug use
    Heparin infusion 2 3 0.65
    β Blockers 4 4 0.80
    ACE inhibitors 12 11 0.81